Haematological Malignancies
Course
In
Description
-
Type
Course
-
Duration
2 Days
This course reviews the haematological system and provides an overview on the spectrum of haematological cancers. Suitable for: Both medical and non-medical staff within the pharmaceutical industry. This course is suitable for clinical research, medical information, regulatory affairs, biometrics and strategic marketing personnel.
Reviews
Teachers and trainers (2)
Dr Mike Potter
Chairman
Consultant Haematologist The Royal Marsden Hospital Surrey, UK
Dr Simon Rule
Chairman
Consultant in Haematology Derriford Hospital Plymouth, UK
Course programme
Course Description
The pathophysiology of haematological malignancies such as leukaemias, lymphomas and myeloma are discussed along with their common treatments such as high dose chemotherapy and total body irradiation. The issues and complications of bone marrow and stem cell transplant will be reviewed. Matters relating to clinical trial issues including ethical considerations and NICE directives will be examined. Additional therapeutic options such as immunotherapy and vaccines will also be considered.
Case studies, quizzes and open discussion will form an integral part of the programme.
CPD accreditation:
Healthcare's programmes are approved by the Faculty of Pharmaceutical Medicine for CPD accreditation.
Topics to be covered include:
- The formation and maturation of blood cells
- Classification and epidemiology of haematological malignancies
- Presentation, diagnosis and staging
- Chemotherapy and irradiation
- Clinical trial issues
- Future therapeutic options
Additional information
Haematological Malignancies